Dr Reddys Laboratories (RDY) EBT Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded EBT Margin of 14.16% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 6.68 percentage points from 20.84% a year earlier but up 7.31 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' EBT Margin came in at 10.72% as of Sep 30, 2026, down 11.55 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 16.31%, down 7.30 percentage points from FY2025.
- Annual EBT Margin has a five-year change of +2.40 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBT Margin came in at 23.62% in FY2025 (-2.12 pp), 25.73% in FY2024 (+1.20 pp), 24.53% in FY2023 (+9.46 pp) and 15.07% in FY2022 (+1.16 pp).
- Quarterly EBT Margin has ranged from 2.65% in fiscal Q4 2026 to 27.81% in fiscal Q2 2024 over the past five years.
- On a year-over-year basis, EBT Margin has declined for six consecutive quarters, with an average year-over-year change of -6.88 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 22.81 percentage points in fiscal Q4 2023, against a drop of 20.93 percentage points in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 6.85% (Q1 2027), 2.65% (Q4 2026) and 17.68% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 20.41% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 14.16% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.16% |
| Jun 30, 2026 | 6.85% |
| Mar 31, 2026 | 2.65% |
| Dec 31, 2025 | 17.68% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 22.29% |
| Mar 31, 2025 | 23.58% |
| Dec 31, 2024 | 22.42% |
| Sep 30, 2024 | 23.91% |
| Jun 30, 2024 | 24.53% |
| Mar 31, 2024 | 22.61% |
| Dec 31, 2023 | 25.30% |
| Sep 30, 2023 | 27.81% |
| Jun 30, 2023 | 27.78% |
| Mar 31, 2023 | 27.37% |
| Dec 31, 2022 | 21.12% |
| Sep 30, 2022 | 24.15% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 4.57% |
| Dec 31, 2021 | 11.30% |
Dr Reddys Laboratories EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();